What prognosis for Ebstein's anomaly without surgery? Hassan II teaching hospital experience

La Tunisie Medicale
|October 6, 2016
PubMed

Insights

Symptomatic medical treatment for Ebstein malformation, a heart condition, may improve patient outcomes. This study highlights the prognosis in pediatric patients receiving only medical management.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Ebstein disease, a congenital heart defect, has seen treatment advancements through surgical interventions.
  • Understanding the prognosis of Ebstein anomaly is crucial for pediatric patient care.

Purpose of the Study:

  • To evaluate the prognosis of Ebstein anomaly in pediatric patients at Hassan II hospital in Fez.
  • To assess the impact of medical management on Ebstein anomaly outcomes.

Main Methods:

  • A descriptive and retrospective study was conducted over a 4-year period.
  • Data from nine pediatric patients diagnosed with Ebstein anomaly were analyzed.

Main Results:

  • The study included seven boys and two girls with a mean age of 5.3 years.
  • Cyanosis was the primary presenting symptom; three patients had associated malformative syndromes.
  • Five out of nine patients survived with medical treatment during a 1-6 year follow-up.

Conclusions:

  • Symptomatic medical treatment for Ebstein malformation appears to positively influence the disease's prognosis in pediatric cases.
  • Further research into optimizing medical management strategies for Ebstein anomaly is warranted.